Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.

AIM Angiogenesis is an important step in the growth of solid malignant tumors. A number of angiogenic factors have been found such as transforming growth factor beta1 (TGF-beta1) and vascular endothelial growth factor (VEGF). However, the roles of TGF-beta1 and VEGF in gastrointestinal carcinogenesis are still unclear. This study was to investigate the expressions of TGF-beta1 and VEGF in gastrointestinal tract malignant tumors, as well as their association with microvessel density (MVD). At the same time, we also observed the localization of TGF-beta1 and its receptor CD105 in gastric malignant tumors. METHODS The expressions of TGF-beta1 and CD105 were detected in 55 fresh specimens of gastric carcinoma and VEGF and CD105 in 44 fresh specimens of colorectal carcinoma by immunohistochemical staining (S-ABC). TGF-beta1 and CD105 in 55 gastric carcinoma tissues on the same slide were detected by using double-stain Immunohistochemistry (DS-ABC). RESULTS Among the 55 cases of gastric carcinoma tissues, 30 were positive for TGF-beta1 (54.55%). The MVD of TGF-beta1 strong positive group (++ approximately +++ 23.22 +/- 5.8) was significantly higher than that of weak positive group (+17.56 +/- 7.2) and negative group (- 17.46 +/- 3.9) (q=4.5, q=5.3207, respectively, P<0.01). In the areas of high expression of TGF-beta1, MVD and the expression of CD105 were also high. Among the 44 cases of colonic carcinoma tissues, 26 were positive for VEGF (59.1%). The expressions of both VEGF and CD105 (MVD) were related with the depth of invasion (F=5.438, P<0.05; F=4.168, P=0.05), lymph node metastasis (F=10.311, P<0.01; F=20.282, P<0.01) and Dukes stage (F=6.196, P<0.01; F=10.274, P<0.01), but not with histological grade (F=0.487, P>0.05). There was a significant correlation between the expression of VEGF and CD105 (MVD) (r=0.720, P<0.01). CONCLUSION Over-expression of TGF-beta1 and VEGF acts as stimulating factors of angiogenesis in gastrointestinal tumors. CD105, as a receptor of TGF-beta1, can regulate the biological effect of TGF-beta1 in tumor angiogenesis. MVD marked by CD105 is more suitable for detecting newborn blood vessels.

[1]  M. Maio,et al.  Differential levels of soluble endoglin (CD105) in myeloid malignancies , 2003, Journal of cellular physiology.

[2]  K. Chayama,et al.  Clinical Significance of Angiogenic Factor Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.

[3]  P. Gong,et al.  Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. , 2002, World journal of gastroenterology.

[4]  B. Xiong,et al.  TGF beta1 expression and angiogenesis in colorectal cancer tissue. , 2002, World journal of gastroenterology.

[5]  M. Maio,et al.  Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies , 2001, Journal of cellular physiology.

[6]  T. Tsushima,et al.  Transforming growth factor‐β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma , 2001 .

[7]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[8]  I. Hampson,et al.  CD 105 antagonizes the inhibitory signaling of transforming growth factor b 1 on human vascular endothelial cells , 1999 .

[9]  A. Ramaswamy,et al.  Elevated expression of endoglin, a component of the TGF‐β‐receptor complex, correlates with proliferation of tumor endothelial cells , 1999, International journal of cancer.

[10]  M. Herlyn,et al.  Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  S. Kumar,et al.  Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. , 1999, Cancer research.

[12]  Y. Maehara,et al.  Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  B. Bodey,et al.  Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. , 1998, Anticancer research.

[14]  P. V. van Diest,et al.  Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis , 1998, The Journal of pathology.

[15]  T. Kawarabayashi,et al.  Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color doppler ultrasound, immunohistochemistry, and microvessel density , 1997, Cancer.

[16]  J. Jing,et al.  [Tumor angiogenesis in node-negative breast carcinoma]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[17]  T. Tsushima,et al.  Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. , 2001, Cancer.